Kristina (Kris) Bieker, PhD focuses her practice on strategic patent portfolio development for early stage companies and the handling of intellectual property matters for companies and investors during financings, public offerings, mergers and strategic partnerships. She works to build and preserve layered exclusivity profiles that are structured to peak in strength during the critical periods of a product’s branded commercial sales life. According to IAM Patent 1000, Kris “steps in when the opportunity to monetise a right arises.”
She represents private- and public-side biotech, pharmaceutical and medical device companies and advises clients on matters relating to patent prosecution, including patentability, non-infringement and invalidity opinions, licensing, joint development agreements and patent enforcement. Additionally, she performs IP due diligence on potential investments for some of the top venture capital firms and serial entrepreneurs in the world, some with whom her relationships span a period of more than 15 years. She has been described by clients as having “the commercial savvy and interpersonal skills to quickly ink lucrative licensing contracts with even the most recalcitrant third parties.”
Kris’ experience encompasses cellular immunotherapies; gene therapy; nano and viral systems for oncolytic, gene therapy and vaccine indications; preventative medicine; treatments for devastating neurological and other tissue injuries; treatments—and more critically cures—for developmental and progressive neurological diseases such as autism, ALS and Alzheimer’s.
Prior to joining McDermott, Kris spent 22 years as a co-founder of an IP boutique dedicated to life sciences patent prosecution, serving as a managing partner for the last eight years.
During her academic career, Kris conducted cell biology, genetics and neurobiology research using molecular biology and biochemistry techniques. Select first-author research and review articles have been published in Cell, EMBO Journal, Proceedings of the National Academy of Sciences, Genomics and Trends in Genetics.
*Matter handled prior to joining McDermott.
Education
Boston College Law School, JD, cum laude, 1996
Princeton University, PhD, Molecular Biology, 1991
Princeton University, MA, Biology, 1989
Swarthmore College, BA, Biology, 1986
Admissions
Massachusetts
Courts / Agencies
US Patent and Trademark Office
Partner | Boston
Boston: +1 617 535 4046
Boston: +1 617 535 3800
Winter 2018
September 12, 2018
June 4, 2018
March 23, 2018
February 2, 2018
January 26, 2018
January 25, 2018
January 24, 2018
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott from representing any other person or firm in any matter; and will not obligate McDermott to keep confidential the information you provide. McDermott cannot enter into an attorney-client relationship with you until McDermott has determined that doing so will not create a conflict of interest and until you and McDermott have entered into a written agreement or engagement letter that sets forth the terms of our relationship.
We use cookies to improve the functionality and performance of this site. By continuing to use this site, you are providing us with your consent to our use of cookies. Please see our Privacy Policy for details.